Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SKIP modifies gene expression by affecting both transcription and splicing.
Nagai K, Yamaguchi T, Takami T, Kawasumi A, Aizawa M, Masuda N, Shimizu M, Tominaga S, Ito T, Tsukamoto T, Osumi T. Nagai K, et al. Among authors: masuda n. Biochem Biophys Res Commun. 2004 Apr 2;316(2):512-7. doi: 10.1016/j.bbrc.2004.02.077. Biochem Biophys Res Commun. 2004. PMID: 15020246
Validation of a New Scoring Method to Assess the Efficacy of Rapid Initiation and Titration of Combination Pharmacotherapy for Patients Hospitalized with Acute Decompensated Heart Failure with Reduced and Mildly Reduced Ejection Fraction.
Asano T, Maeno Y, Nakano M, Taguri M, Miyasaka M, Nakai D, Miyazaki I, Nasu T, Tanimoto S, Masuda N, Morino Y, Isshiki T, Ogata N. Asano T, et al. Among authors: masuda n. J Clin Med. 2024 May 8;13(10):2775. doi: 10.3390/jcm13102775. J Clin Med. 2024. PMID: 38792317 Free PMC article.
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Takano T, Masuda N, Ito M, Inoue K, Tanabe Y, Kawaguchi K, Yasojima H, Bando H, Nakamura R, Yamanaka T, Ishida K, Aruga T, Yanagita Y, Tokunaga E, Aogi K, Ohno S, Kasai H, Kataoka TR, Morita S, Toi M. Takano T, et al. Among authors: masuda n. Breast Cancer Res Treat. 2024 May 20. doi: 10.1007/s10549-024-07333-7. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38767786
1,177 results